rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Celanese Corporation

CE · NYSE

MaterialsChemicalsNot moving yet

CE stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 18 weeks. It is 8.5% below that average now. Chemicals: 24% of its 85 stocks in an uptrend (−5 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 18
Industry in uptrend
24% -5 in 4 wk
Insider buys, 12 months
$823K
Insider sales, 12 months
$0
Officials’ trades on record
28

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.

17 Apr – 16 Oct
18%38%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has been slipping. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$672KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

28 disclosed lines: House 25, Senate 3, executive 0; 9 people.

WhoDidAmountTraded
Byron Donalds House: U.S. House ClerkFL19sold$1k–$15k12 Aug 2022filed 8 Nov 2024
Byron Donalds House: U.S. House ClerkFL19soldspouse$1k–$15k12 Aug 2022filed 8 Nov 2024
Kathy E. Manning House: U.S. House ClerkNC06soldjoint$1k–$15k3 Aug 2022filed 14 Sep 2022
Kathy E. Manning House: U.S. House ClerkNC06boughtjoint$1k–$15k20 Jul 2022filed 10 Aug 2022
Dwight Evans House: U.S. House ClerkPA03sold$1k–$15k30 Mar 2022filed 25 Apr 2022
Tommy Tuberville Senate: U.S. Senate eFDSenatorsoldjoint$1k–$15k30 Mar 2022filed 8 Apr 2022
John H. Rutherford House: U.S. House ClerkFL04sold$15k–$50k16 Mar 2022filed 19 Apr 2022
Byron Donalds House: U.S. House ClerkFL19bought$1k–$15k3 Aug 2021filed 8 Nov 2024
Byron Donalds House: U.S. House ClerkFL19boughtspouse$1k–$15k3 Aug 2021filed 8 Nov 2024
Dwight Evans House: U.S. House ClerkPA03bought$1k–$15k26 May 2021filed 9 Jul 2021
Tommy Tuberville Senate: U.S. Senate eFDSenatorboughtjoint$1k–$15k29 Mar 2021filed 23 Jul 2021
John Hoeven Senate: U.S. Senate eFDSenatorbought$50k–$100k30 May 2019filed 3 Jun 2019

Insiders

Buy orders, 12 months5
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Chuck KyrishSVP & CFObought1,400at $45.5314 Aug 2026filed 17 Aug 2026
Chuck KyrishSVP & CFObought100at $45.5114 Aug 2026filed 17 Aug 2026
Chuck KyrishSVP & CFObought800at $45.5114 Aug 2026filed 17 Aug 2026
Mark Christopher MurraySVP - Acetylsbought2,153at $45.5211 Aug 2026filed 12 Aug 2026
Ashley B. DuffieSVP & GCbought600at $45.6011 Aug 2026filed 13 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Chuck Kyrish Company insiderSVP & CFO · last 14 Aug 20262 · 0
Ashley B. Duffie Company insiderSVP & GC · last 11 Aug 20261 · 0
Mark Christopher Murray Company insiderSVP - Acetyls · last 11 Aug 20267 · 0
Deborah J. Kissire Company insiderDirector · last 10 Aug 20261 · 0
Edward G. Galante Company insiderDirector · last 10 Aug 20261 · 0
Kathryn Hill Company insiderDirector · last 10 Aug 20260 · 0
Kim K.W. Rucker Company insiderDirector · last 10 Aug 20260 · 0
Anne P. Noonan Company insiderDirector · last 11 May 20260 · 0
Bruce E. Chinn Company insiderDirector · last 11 May 20260 · 0
Christopher J. Kuehn Company insiderDirector · last 11 May 20260 · 0
Ganesh Moorthy Company insiderDirector · last 11 May 20263 · 0
Michael Koenig Company insiderDirector · last 11 May 20260 · 0

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+15%
MEOH MethanexLeading+12%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202520.5%
Operating profit marginFY 2025 · to 31 Dec 2025-8.2%
Free cash flow marginFY 2025 · to 31 Dec 20258.4%
Return on capital employedFY 2025 · to 31 Dec 2025-4.4%
Debt to equityFY 2025 · to 31 Dec 20253.41×
Interest coverFY 2025 · to 31 Dec 2025-1.12×
Research spendFY 2025 · to 31 Dec 20251.3%
Share count trendFY 2025 · to 20 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.3B
Free cash flowFY 2025 · to 31 Dec 2025$803.0M

Analyst forecasts

No analyst forecasts yet.